OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience

por Chiang, Chia-Chun, Starling, Amaal J.
Publicado 2017

Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report

por Arca, Karissa N., Starling, Amaal J.
Publicado 2020

Variability of the modified Balance Error Scoring System at baseline using objective and subjective balance measures

por Starling, Amaal J, Leong, Danielle F, Bogle, Jamie M, Vargas, Bert B
Publicado 2015

Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States

por Starling, Amaal J., Kymes, Steven, Asher, Divya, Soni-Brahmbhatt, Seema, Karnik-Henry, Meghana
Publicado 2023

Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial

por Ashina, Messoud, Tepper, Stewart J., Gendolla, Astrid, Sperling, Bjørn, Ettrup, Anders, Josiassen, Mette Krog, Starling, Amaal J.
Publicado 2023

Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)

por Kuruvilla, Deena E., Mann, Joseph I., Tepper, Stewart J., Starling, Amaal J., Panza, Gregory, Johnson, Michael A. L.
Publicado 2022

Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, ph...

por Shapiro, Robert E., Hochstetler, Helen M., Dennehy, Ellen B., Khanna, Rashna, Doty, Erin Gautier, Berg, Paul H., Starling, Amaal J.
Publicado 2019

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

por Cowan, Robert P., Marmura, Michael J., Diener, Hans-Christoph, Starling, Amaal J., Schim, Jack, Hirman, Joe, Brevig, Thomas, Cady, Roger
Publicado 2022

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine

por Ford, Janet H., Kurth, Tobias, Starling, Amaal J., Ayer, David W., Wietecha, Linda A., Port, Martha D., Rettiganti, Mallikarjuna, Ruff, Dustin D.
Publicado 2020

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medicat...

por Marmura, Michael J., Diener, Hans‐Christoph, Cowan, Robert P., Tepper, Stewart J., Diamond, Merle L., Starling, Amaal J., Hirman, Joe, Mehta, Lahar, Brevig, Thomas, Cady, Roger
Publicado 2021

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

por Starling, Amaal J, Tepper, Stewart J, Marmura, Michael J, Shamim, Ejaz A, Robbins, Matthew S, Hindiyeh, Nada, Charles, Andrew C, Goadsby, Peter J, Lipton, Richard B, Silberstein, Stephen D, Gelfand, Amy A, Chiacchierini, Richard P, Dodick, David W
Publicado 2018

Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)

por Lipton, Richard B, Serrano, Daniel, Buse, Dawn C, Pavlovic, Jelena M, Blumenfeld, Andrew M, Dodick, David W, Aurora, Sheena K, Becker, Werner J, Diener, Hans-Christoph, Wang, Shuu-Jiun, Vincent, Maurice B, Hindiyeh, Nada A, Starling, Amaal J, Gillard, Patrick J, Varon, Sepideh F, Reed, Michael L
Publicado 2015